Peking University People's Hospital, Peking University Hepatology Institute, Department of Infectious Diseases, Beijing, China.
PLoS One. 2013 Aug 16;8(8):e71483. doi: 10.1371/journal.pone.0071483. eCollection 2013.
Limited information is available on the molecular epidemiology of GII.4 Sydney-associated diarrhea in China in the winter of 2012-13 during the global epidemic associated with the emergence of GII.4 Sydney.
Fecal specimens collected from 171 diarrhea outpatients (one from each) between late October 2012 and the middle of March 2013 were examined for NoV by reverse transcription-polymerase chain reaction and sequences corresponding to both the NoV partial polymerase and partial capsid regions were analyzed phylogenetically. Clinical characteristics of GII.4 Sydney cases versus other NoV-positive cases detected in a previous study were compared statistically.
Twenty-six (15.2%, 26/171) outpatients with diarrhea were infected with NoV. Twenty-two of the 26 (84.6%) identified NoV strains clustered into GII.4 Sydney. There was a significant difference in symptoms of fever (χ(2), P<0.05 ), abdominal pain (χ(2), P<0.05 ) and diarrhea frequency (Mann-Whitney U test, P<0.05) between the GII.4 Sydney case group and other NoV-positive case group.
The new NoV variant, GII.4 Sydney, has been circulating in Beijing, China and became the predominant strain in the winter of 2012-13. GII.4 Sydney causes severe fever, abdominal pain and higher diarrhea frequency clinically compared to other NoV infections.
在 2012-13 年冬季全球与 GII.4 Sydney 出现相关的流行期间,有关中国 2012 年冬季 GII.4 Sydney 相关腹泻的分子流行病学的信息有限。
2012 年 10 月末至 2013 年 3 月中旬期间,采集了 171 例腹泻门诊患者(每位患者采集 1 份粪便标本)的粪便标本,通过逆转录-聚合酶链反应检测诺如病毒(NoV),并对 NoV 部分聚合酶和部分衣壳区的序列进行了系统进化分析。对本研究中 GII.4 Sydney 病例与之前研究中检测到的其他 NoV 阳性病例的临床特征进行了统计学比较。
26 例(15.2%,26/171)腹泻患者感染了 NoV。26 株 NoV 中 22 株(84.6%)鉴定为 GII.4 Sydney。GII.4 Sydney 病例组与其他 NoV 阳性病例组在发热(χ(2),P<0.05)、腹痛(χ(2),P<0.05)和腹泻频率(Mann-Whitney U 检验,P<0.05)等症状方面存在显著差异。
新型 NoV 变异株 GII.4 Sydney 已在中国北京传播,并成为 2012-13 年冬季的主要流行株。与其他 NoV 感染相比,GII.4 Sydney 引起更严重的发热、腹痛和更高的腹泻频率。